Modern evidence has largely discredited the long-held belief that intravenous contrast routinely causes nephropathy. Early studies with high-osmolality agents and no controls suggested “contrast-induced nephropathy,” but recent research using controlled cohorts shows contrast is rarely the direct cause of acute kidney injury (AKI). Guidelines now favor the term “contrast-associated AKI,” emphasizing correlation over causation. In patients with estimated glomerular filtration rate 30 mL/min or greater, contrast can be safely used without delay or prophylactic hydration. Overly cautious policies delay diagnosis and harm patient care, especially in emergency settings. Contrast should be viewed as a vital diagnostic tool, not a toxin.